Buy Novavax Stock | NVAX Stock Price & Latest News | Public
NVAX

Novavax

$0.00 (0.00%)Today

    About NVAX

    Novavax, Inc. is operates as a clinical-stage biotechnology company, which focuses on the discovery, development and commercialization of vaccines to prevent infectious diseases. It produces vaccine candidates to respond to both known and emerging disease threats by usi...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    1.73
    0.78
    -0.18
    -1.13
    Q4 2019
    Q1 2020
    Q2 2020
    Q3 2020

    Expected EPS
    Q3 2020

    $1.73

    Actual EPS
    Q3 2020

    Stats

    Market Cap$6,81B
    Volume96,29k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$189.40
    1 Year Low$3.54
    Open$107.42
    High$109.52
    Low$105.15

    Buy any stock with any amount of money.

    Download the App
    Download the app